Gene · 3981
Papers3,259
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,259
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Alternative splicing in multiple myeloma is associated with the non-homologous end joining pathway. | Blood Cancer J | 2023 | 36670103 | PubTator, text mining | PubMed |
| Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development. | J Clin Immunol | 2023 | 36648576 | PubTator, text mining | PubMed |
| TEAD Proteins Associate With DNA Repair Proteins to Facilitate Cellular Recovery From DNA Damage. | Mol Cell Proteomics | 2023 | 36640924 | PubTator, text mining | PubMed |
| ATM suppresses c-Myc overexpression in the mammary epithelium in response to estrogen. | Cell Rep | 2023 | 36640339 | PubTator, text mining | PubMed |
| International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood. | Endocr Rev | 2023 | 36635911 | PubTator, text mining | PubMed |
| Extru-seq: a method for predicting genome-wide Cas9 off-target sites with advantages of both cell-based and in vitro approaches. | Genome Biol | 2023 | 36627653 | PubTator, text mining | PubMed |
| Human DNA ligases I and III have stand-alone end-joining capability, but differ in ligation efficiency and specificity. | Nucleic Acids Res | 2023 | 36625284 | PubTator, text mining | PubMed |
| Fluorescence and phosphorescence lifetime imaging reveals a significant cell nuclear viscosity and refractive index changes upon DNA damage. | Sci Rep | 2023 | 36624137 | PubTator, text mining | PubMed |
Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study. | Ann Hematol | 2023 | 36622392 | PubTator, text mining | PubMed |
| Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status. | J Ovarian Res | 2023 | 36611214 | PubTator, text mining | PubMed |
| Circ_0089282 inhibits carbon black nanoparticle-induced DNA damage by promoting DNA repair protein in the lung. | Toxicol Sci | 2023 | 36610987 | PubTator, text mining | PubMed |
| Human DNA-dependent protein kinase activation mechanism. | Nat Struct Mol Biol | 2023 | 36604499 | PubTator, text mining | PubMed |
| Pol X DNA polymerases contribute to NHEJ flexibility. | Nat Struct Mol Biol | 2023 | 36587186 | PubTator, text mining | PubMed |
| Autoimmune Neutropenias: Update on Clinical and Biological Features in Children and Adults. | Hemasphere | 2023 | 36570693 | PubTator, text mining | PubMed |
| The oncogenic driving force of CD30 signaling-induced chromosomal instability in adult T-cell leukemia/lymphoma. | Cancer Sci | 2023 | 36541483 | PubTator, text mining | PubMed |
| Polλ promotes microhomology-mediated end-joining. | Nat Struct Mol Biol | 2023 | 36536104 | PubTator, text mining | PubMed |
| Efficient single copy integration via homology-directed repair (scHDR) by 5'modification of large DNA donor fragments in mice. | Nucleic Acids Res | 2023 | 36533445 | PubTator, text mining | PubMed |
| The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions. | J Allergy Clin Immunol | 2023 | 36456360 | PubTator, text mining | PubMed |
| Double-strand break repair and mis-repair in 3D. | DNA Repair (Amst) | 2023 | 36436496 | PubTator, text mining | PubMed |
| The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review. | Oncogene | 2023 | 36434179 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3981/papers?page=19